Search alternatives:
point decrease » point increase (Expand Search)
026 decrease » _ decrease (Expand Search), nn decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
point decrease » point increase (Expand Search)
026 decrease » _ decrease (Expand Search), nn decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
67101
-
67102
-
67103
A super-SILAC based proteomics analysis of diffuse large B-cell lymphoma-NOS patient samples to identify new proteins that discriminate GCB and non-GCB lymphomas
Published 2019“…In this study we aimed to identify additional proteins that are differentially expressed between GCB and non-GCB DLBCL. A reference super-SILAC mix, including proteins of eight B-cell lymphoma cell lines, was mixed with proteins isolated from seven non-GCB DLBCL and five GCB DLBCL patient tissue samples to quantify protein levels. …”
-
67104
Image_14_Susceptibility-Guided Therapy vs. Bismuth-Containing Quadruple Therapy as the First-Line Treatment for Helicobacter pylori Infection: A Systematic Review and Meta-Analysis...
Published 2022“…</p>Results<p>Five studies with 2,110 H. pylori-infected patients were enrolled. …”
-
67105
Image_10_Susceptibility-Guided Therapy vs. Bismuth-Containing Quadruple Therapy as the First-Line Treatment for Helicobacter pylori Infection: A Systematic Review and Meta-Analysis...
Published 2022“…</p>Results<p>Five studies with 2,110 H. pylori-infected patients were enrolled. …”
-
67106
Image_4_Susceptibility-Guided Therapy vs. Bismuth-Containing Quadruple Therapy as the First-Line Treatment for Helicobacter pylori Infection: A Systematic Review and Meta-Analysis....
Published 2022“…</p>Results<p>Five studies with 2,110 H. pylori-infected patients were enrolled. …”
-
67107
Image_6_Susceptibility-Guided Therapy vs. Bismuth-Containing Quadruple Therapy as the First-Line Treatment for Helicobacter pylori Infection: A Systematic Review and Meta-Analysis....
Published 2022“…</p>Results<p>Five studies with 2,110 H. pylori-infected patients were enrolled. …”
-
67108
Image_9_Susceptibility-Guided Therapy vs. Bismuth-Containing Quadruple Therapy as the First-Line Treatment for Helicobacter pylori Infection: A Systematic Review and Meta-Analysis....
Published 2022“…</p>Results<p>Five studies with 2,110 H. pylori-infected patients were enrolled. …”
-
67109
Image_12_Susceptibility-Guided Therapy vs. Bismuth-Containing Quadruple Therapy as the First-Line Treatment for Helicobacter pylori Infection: A Systematic Review and Meta-Analysis...
Published 2022“…</p>Results<p>Five studies with 2,110 H. pylori-infected patients were enrolled. …”
-
67110
Image_3_Susceptibility-Guided Therapy vs. Bismuth-Containing Quadruple Therapy as the First-Line Treatment for Helicobacter pylori Infection: A Systematic Review and Meta-Analysis....
Published 2022“…</p>Results<p>Five studies with 2,110 H. pylori-infected patients were enrolled. …”
-
67111
Image_1_Susceptibility-Guided Therapy vs. Bismuth-Containing Quadruple Therapy as the First-Line Treatment for Helicobacter pylori Infection: A Systematic Review and Meta-Analysis....
Published 2022“…</p>Results<p>Five studies with 2,110 H. pylori-infected patients were enrolled. …”
-
67112
Image_8_Susceptibility-Guided Therapy vs. Bismuth-Containing Quadruple Therapy as the First-Line Treatment for Helicobacter pylori Infection: A Systematic Review and Meta-Analysis....
Published 2022“…</p>Results<p>Five studies with 2,110 H. pylori-infected patients were enrolled. …”
-
67113
Image_2_Susceptibility-Guided Therapy vs. Bismuth-Containing Quadruple Therapy as the First-Line Treatment for Helicobacter pylori Infection: A Systematic Review and Meta-Analysis....
Published 2022“…</p>Results<p>Five studies with 2,110 H. pylori-infected patients were enrolled. …”
-
67114
Image_11_Susceptibility-Guided Therapy vs. Bismuth-Containing Quadruple Therapy as the First-Line Treatment for Helicobacter pylori Infection: A Systematic Review and Meta-Analysis...
Published 2022“…</p>Results<p>Five studies with 2,110 H. pylori-infected patients were enrolled. …”
-
67115
Table_1_Susceptibility-Guided Therapy vs. Bismuth-Containing Quadruple Therapy as the First-Line Treatment for Helicobacter pylori Infection: A Systematic Review and Meta-Analysis....
Published 2022“…</p>Results<p>Five studies with 2,110 H. pylori-infected patients were enrolled. …”
-
67116
Table_2_Susceptibility-Guided Therapy vs. Bismuth-Containing Quadruple Therapy as the First-Line Treatment for Helicobacter pylori Infection: A Systematic Review and Meta-Analysis....
Published 2022“…</p>Results<p>Five studies with 2,110 H. pylori-infected patients were enrolled. …”
-
67117
Image_7_Susceptibility-Guided Therapy vs. Bismuth-Containing Quadruple Therapy as the First-Line Treatment for Helicobacter pylori Infection: A Systematic Review and Meta-Analysis....
Published 2022“…</p>Results<p>Five studies with 2,110 H. pylori-infected patients were enrolled. …”
-
67118
Image_13_Susceptibility-Guided Therapy vs. Bismuth-Containing Quadruple Therapy as the First-Line Treatment for Helicobacter pylori Infection: A Systematic Review and Meta-Analysis...
Published 2022“…</p>Results<p>Five studies with 2,110 H. pylori-infected patients were enrolled. …”
-
67119
-
67120
Cohesin depletion reduces long-range interactions between PRE-containing regions in the <b><i>invected-engrailed</i></b><b> locus in BG3 cells.</b>
Published 2013“…Anchors <b>a</b> and <b>d</b>, shown in the top and bottom panels, are outside of the complex and show high local interactions but do not interact with points inside the complex. …”